đź§  Parkinson's Digest Give Feedback
  • All
  • Research
  • Trials
  • News
18F-DOPA II - PET Imaging Optimization
Trial Phase 3 Recruiting Feb. 8, 2026
prTMS as an Intervention for Bradykinesia in Parkinson's Disease
Trial N/A Recruiting Feb. 8, 2026
Association Between a 1-Year Group-Based Telerehabilitation Program and the Quality of Life of People With Parkinson's Disease: An Observational Study.
Research Archives of physical medicine and rehabilitation Feb. 8, 2026
Optimized cortical EEG modeling for Parkinson disease diagnosis with snow Shepherd Stride tuning mechanism.
Research Cognitive neurodynamics Feb. 6, 2026
Language skills in Parkinson's disease: state of the art.
Research Dementia & neuropsychologia Feb. 6, 2026
Predictive factors of global cognitive impairment in de novo Parkinson disease with normal cognition at baseline: a 10-year cohort study.
Research Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology Feb. 6, 2026
Effects of Directional Subthalamic Deep Brain Stimulation on Gait and Balance in Parkinson's Disease Patients
Trial N/A Completed Feb. 5, 2026
Medico-economic Evaluation Rehabilitation by Serious Games at Home for the Management of Patients With Parkinson's Disease Suffering From Gait and Balance Disorders
Trial N/A Recruiting Feb. 5, 2026
Study on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital Biomarkers
Trial N/A Recruiting Feb. 5, 2026
In vitro-prepared A30P alpha-synuclein fibrils adopt the conserved and disease-relevant Greek key fold.
Research bioRxiv : the preprint server for biology Feb. 5, 2026
Unexpected 123 I FP-CIT (DaT SCAN) Uptake in Palpebral Conjunctival Melanoma.
Research Clinical nuclear medicine Feb. 5, 2026
Research Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM Device
Trial N/A Enrolling by invitation Feb. 4, 2026
Evaluation of the Effects of Aquatic Therapy on Activities of Daily Living, Walking, Balance, Posture, Pain, and Depression in Parkinson's Patients
Trial N/A Recruiting Feb. 4, 2026
Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease
Trial Phase 2 Completed Feb. 4, 2026
A randomized safety and feasibility crossover trial of two Mediterranean-ketogenic interventions in individuals with Parkinson's disease.
Research Journal of Parkinson's disease Feb. 4, 2026
PRKN activation for mitophagy requires an NME3-regulated phosphatidic acid signal that separates mitochondria from endoplasmic reticulum tethering.
Research Autophagy Feb. 4, 2026
Seasonal Depression, Depression, and Parkinson’s Disease
News A Closer Look Archives | American Parkinson Disease Association Feb. 3, 2026
Retinal Imaging in Neurodegenerative Disease
Trial N/A Recruiting Feb. 3, 2026
LIFUP for Treatment of Motor Deficits in Parkinson's Disease
Trial N/A Completed Feb. 3, 2026
Neural substrates of speech disorders in Parkinson's disease: A narrative review of the evidence from task-based and resting-state fMRI studies.
Research Brain and language Feb. 3, 2026
Previous Next

Parkinson's Digest provides access to the latest Parkinson's disease news, research, and clinical trials.

Feedback | Privacy Policy | Source Code

Created by Brian Gaudino. Data sourced from ClinicalTrials.gov, PubMed, and other public sources.

Parkinson's Digest is provided for informational and educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding medical decisions.

© 2026 Parkinson's Digest